Supplier of Premium Ingredients to the Food, Nutritional & Personal Care Industries
Nutralliance Announces GRAS Approval of Ildong Biosciences Probiotics
(YORBA LINDA, CA) - Ana Maria Cuentas, Director of Probiotics for Nutralliance, has announced that its line of probiotics, manufactured by Ildong Biosciences (exclusively represented by Nutralliance), has obtained self-affirmed GRAS status, now known as independent conclusion of GRAS.
The GRAS conclusion covers strains in Ildong’s 11 lactic acid-producing species: Bacillus coagulans, Bifidobacterium breve, Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus casei/paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus johnsonii, Lactobacillus reuteri, Lactococcus lactis, and Streptococcus thermophilus.
GRAS conclusion will expand the use capabilities for innovating in the continually expanding probiotic product market. “The probiotics area has gotten traction and is growing as new scientific data flourishes and innovation in terms of benefits and applications are discovered,” Cuentas commented. “The strains have gone through stringent screening processes to ensure their safety and efficacy, and we strive to provide, not a replacement product, but one that is able to work synergistically with existing or new formulations.”
This new probiotic line is distinguished by its patented quadruple-coating technology which protects the strains’ structure and integrity, thus allowing them to arrive alive and intact to the destination in the lower GI tract. The four-layer coating system consists of guar gum, hyaluronic acid, maltodextrin and a soy protein isolate, all non-GMO. Cuentas explained that this unique layer provides superlative protection against moisture, humidity, air, gastric acid, bile salts and heat.
Cuentas added that all Ildong Bioscience strains are whole genome sequenced, Kosher and non-GMO and that there is potential to include additional lactic acid bacterial strains from Ildong’s portfolio soon. Nonetheless, Nutralliance and Ildong continue to expand their research including in vitro, in vivo and human clinical studies to further understand the benefits of the probiotics and the coating beyond enhanced survival and stability.
Folium Biosciences Names Nutralliance a Preferred U.S. Distributor of Company’s Hemp-Derived Non-Psychoactive Cannabinoid (CBD) Products
Colorado Springs, Colo. and Yorba Linda, Calif. – September 3, 2020 – Hemp-derived non-psychoactive cannabinoid manufacturer Folium Biosciences and premium ingredient sales and marketing company Nutralliance have entered a distribution partnership that grants Nutralliance the right to distribute Folium’s industry leading 0.0% THC broad spectrum CBD oil products in the United States, and establishes Folium as Nutralliance’s exclusive CBD supplier.
“Nutralliance shares Folium’s commitment to exceptional quality,” said Folium Chief Executive Officer and Co-founder Kashif Shan. “That commitment coupled with their respected relationship-based approach to ingredient sales makes them the perfect partner to connect food & beverage, nutrition, animal nutrition and cosmeceutical product manufacturers with Folium’s phytocannabinoid-rich hemp oil raw materials and white-labeled products.”
“The consumers our customers serve demand premium ingredients, and we’re committed to providing them with ingredient solutions that enable them to meet that growing need,” said Brian Salerno, Nutralliance President and CEO. “Not all hemp is created equal, and Folium’s leadership in industrial hemp quality, safety and innovation is unmatched. That makes them a perfect addition to our expanding catalog of superior, science-based ingredients.”
Headquartered in Colorado Springs, Colo., Folium Biosciences is a vertically integrated B2B producer, manufacturer, and distributor of hemp-derived nonpsychoactive cannabinoids. Built on the core tenets of quality, science, scale, and innovation, Folium Biosciences controls all aspects of the supply chain from genetics and extraction to bulk and finished products. Folium Biosciences’ team of scientists, chemists, engineers, and other committed professionals delivers the world’s highest-quality hemp-derived non-psychoactive cannabinoids products through a proprietary process, resulting in a THC content of 0.0%. Folium Biosciences was the first hemp company to be issued a Certificate of Free Sale and a Manufactured Food Establishment License by the Colorado Department of Public Health and Environment and continues to lead the industry in regulatory compliance and governance.
Nutralliance is a premium-ingredient sales and marketing company focused on servicing the dietary supplement, functional food, and personal care industries within the United States. Founded in 2002 by industry veteran Brian Salerno, the company’s focus is on the ability to cater to its customers’ specific needs while maintaining an honest commitment to high-quality product standards delivered at a competitive price and in a timely manner.
Nutralliance exclusively represents Ildong Bioscience and their patented Quadruple Coated Probiotics for enhanced stability and survivability. Take a look at a quick presentation we had the pleasure of doing for Organic & Natural's The Nourish Mint!
Recent Articles from Online Magazines
Nutralliance Announces Distributor Agreement with Globionic: Launches Lavitol® DHQ in North America
YORBA LINDA, CA –Nutralliance has signed an exclusive sales and distribution agreement with Globionic, a supplier that specializes in nutraceutical ingredients from Eastern Europe, announced Nutralliance CEO Brian Salerno.
Globionic obtained the exclusive sales rights for Lavitol® dihydroquercetin, a distinctive larch ingredient from Ametis Corp. based in Siberia, Russia. Lavitol DHQ is the first ingredient from the new alliance to be marketed exclusively in North America by Nutralliance.
Globionic was formed to locate unique and wild-sourced ingredients from Eastern Europe companies to bring their products to the USA or expand their business if there is already a presence here, according to Globionic president and CEO Bill Knudson. “There is an abundance of unique resources specific to this region. Many ingredient suppliers there, however, tend to lack the understanding of how to successfully market their researched ingredients in the US. There are numerous cultural, language, transportation and financing hurdles that hinder their expansion in North America, and Globionic was created to bridge those issues,” he explains.
Lavitol® dihydroquercetin (DHQ), obtained from the Dahurian Larch (Larix gmelinii ) is distinctive in chemical profile and in biological actions from arabinogalactan, the common extract of larch trees. Lavitol DHQ is known to be one of nature's more powerful antioxidants and helps recycle vitamin C while limiting its oxidation. Lavitol DHQ is also scientifically shown to support cardiovascular, respiratory immune, eye/vision, skin, liver and endocrine health.
Lavitol DHQ also has a potent sustainability story – it is extracted via a patented technology from larch tree stumps left behind from wood industry harvesting. Lavitol is produced year-round with an annual production of 13 tons of finished material in a state-of-the-art, ISO 9001:2015, ISO 22000-2005, and HACCP-compliant facility.
“Lavitol DHQ will provide brands with a heavily researched and unique ingredient for a wide range of applications and consumer needs,” says Salerno. “And this is just one of many similar quality ingredients to come from Globionic, a company that itself has a unique position in the supply-side arena.”
Knudson comments, “Out of the many distributors out there in this arena, Nutralliance was selected to be our exclusive distribution partner because of its stellar reputation in the industry for transparency, diligence, follow-through, testing and shipping expertise. All of which align with Globionic’s core principles that we have promised to our partners."
Click to view full online article
Nutralliance, KÄÄPÄ Biotech enter sales, distribution agreement for Nordic Mushrooms extracts
Nutralliance (Yorba Linda, CA) signed an exclusive sales and distribution agreement with Finland-based KÄÄPÄ Biotech Ltd. for its Nordic Mushrooms wholesale mushroom extract product line, which includes Finnish-grown, organic mushrooms: chaga (Inonotus obliquus), reishi (Ganoderma lucidum), lion’s mane (Hericum erinaceus), shiitake (Lentinula edodes) and cordyceps (Cordyceps militaris).
“There is an increased demand for high-quality medicinal mushroom products in the North American market area,” said Eric Puro, CEO of KÄÄPÄ Biotech, in a press release. “The origin of the ingredients used in the food supplement industry is getting more important all the time. Our products are 100% of Finnish origin, from the FSC-certified Finnish sawdust substrate, to growing of mushrooms as well as processing and manufacturing of the mushroom extracts. We have full traceability and transparency in our process from spore to shipment. Therefore, we can guarantee premium quality mushroom extracts to the market.”
KÄÄPÄ Biotech invested in ultrasonic assisted extraction technology that utilizes a combination of hot water and alcohol extraction to ensure the extraction of the desired bioactive compounds in each mushroom. The Nordic Mushrooms product line includes mushroom extract powders and liquid extracts.
“The fungi kingdom and especially members of the Basidiomycota phylum (mushrooms) hold tremendous potential for natural, safe, and effective products that support a wide variety of health concerns as well as general well-being,” said Brian Salerno, CEO of Nutralliance. “To adequately fulfill modern North American consumers’ desires for superior quality in efficacy, safety, and traceability as well as sustainability, we wanted to ensure our mycological expert source was able to put checkmarks in all those columns. KÄÄPÄ Biotech is that resource.”
Nutralliance reaches exclusive distribution agreement for Ildong Biosciences' probiotic line.
Nutralliance launches non-GMO, non-soy mixed tocopherols
Nutralliance first to offer non-GMO, non-soy natural vitamin E powder to US market
INGREDIENTS | NORTH AMERICA
Further demonstrating the company’s commitment to premium, science-based ingredients, Nutralliance has announced the launch of Sunvitol E450-SDN — an organic-compliant, non-GMO, clean-label vitamin E product derived exclusively from sunflowers and using total organic excipients/binders.
'We’re very proud of our growing list of Non-GMO Project–verified ingredients. The consumers our customers serve are increasingly demanding pure ingredients, and we’re committed to providing our customers with ingredient solutions that enable them to meet that growing need,' said Brian Salerno, Nutralliance’s president/CEO.
'Our customers know they can count on us for clean-label, organic-compliant products, and we are committed to continuing to increase our organic and non-GMO offerings to help them achieve new levels of business success,' he added.
Sunvitol natural vitamin E is a sunflower-derived 450 IU d-alpha tocopherol. No other sunflower powder or soy-based vitamin E available in the US market can offer the same organic-compliant, certified non-GMO and allergen-free clean label.
Nutralliance offer non-GMO, non-soy natural vitamin E powder to US Market
California-based Nutralliance has launched a sunflower derived vitamin E powder with Non-GMO Project verification
Click here to go to website article!
New York City Marathon
We are extremely proud of one of our Regional Sales Executives, Toby Smeltzer, for representing Nutralliance and completing the 2019 NYC Marathon!